Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03727425 · ClinicalTrials.gov registry record · NA

Robotic Bronchoscopy for Peripheral Pulmonary Lesions

A NA study, sponsored by Auris Health.

Completed
Registry status
NA
Development phase
55
Enrollment target

NCT03727425: Completed NA study, sponsored by Auris Health.

NCT03727425 is a NA study that has completed, run by Auris Health. The registered enrollment target is 55 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03727425, a NA study, has completed, sponsored by Auris Health.

COMPLETED
Registry status
NA
Development phase
55 participants
Enrollment target

Study Summary

In this study, the feasibility of performing robotic navigation of peripheral airways in human subjects for the purpose of biopsying peripheral lung lesions will be evaluated.

Primary Outcome

Computed as the number of patients with device or procedure related adverse events divided by number of patients who underwent the robotic bronchoscopy procedure.

Interventions

  • DEVICE Robotic assisted bronchoscopy

Trial Details

FieldValue
Enrollment Target 55 participants
Start Date 2018-11-01
Est. Completion 2020-06-30
Phase NA
Auris Health

5 total trials

What the finished NCT03727425 record still lists

NCT03727425 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which Robotic assisted bronchoscopy is the first listed.

NCT03727425 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03727425 about?

NCT03727425 is a clinical study titled "Robotic Bronchoscopy for Peripheral Pulmonary Lesions". In this study, the feasibility of performing robotic navigation of peripheral airways in human subjects for the purpose of biopsying peripheral lung lesions will be evaluated.

What is the current status of trial NCT03727425?

This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2018-11-01. Estimated completion is 2020-06-30.

What interventions are being tested in trial NCT03727425?

The interventions under investigation include: Robotic assisted bronchoscopy (DEVICE).

Who is sponsoring clinical trial NCT03727425?

This trial is sponsored by Auris Health, which has 5 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03727425's enrollment target sits among peer trials

55 1264th of 2000 higher than 733 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01638676 · 55 participants · Phase 1

    A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients

  • NCT01906385 · 55 participants · Phase 1

    Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

  • NCT03007030 · 55 participants · Phase 2

    Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery

  • NCT03152058 · 55 participants · Phase 2

    IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03727425, the US trial registry maintained by the National Library of Medicine. NCT03727425 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.